3T场强下中央静脉征鉴别多发性硬化与血清阳性视神经脊髓炎谱系疾病的价值
在临床3T扫描仪上评估中央静脉征(CVS)区分多发性硬化(MS)与视神经脊髓炎谱系疾病(NMOSD)的价值。18例水通道蛋白4抗体阳性NMOSD患者、18例复发缓解型MS患者和25名健康对照接受3T MRI。MS病灶中CVS比例高于NMOSD(80% vs 32%,p < 0.001)。若任一次扫描中超过54%的病灶显示CVS,则诊断MS的准确率为94%(95%CI 81.34–99.32,p < 0.001,敏感度/特异度90%/100%)。
要点
- 3T MRI上MS病灶CVS比例高于NMOSD(80% vs 32%,p < 0.001)。
- CVS比例每增加1个百分点,患者患MS的风险增加10%(OR 1.10,95%CI 1.04–1.16,p = 0.001)。
- 超过54%病灶显示CVS时诊断MS准确率94%(95%CI 81.34–99.32),敏感度90%、特异度100%。
核心结论
- 中央静脉征(CVS)在MS与NMOSD鉴别诊断中的临床价值此前在7T扫描仪上提出,现扩展至临床3T扫描仪,向CVS进入临床实践迈进一步。
研究设计与样本
- 18例水通道蛋白4抗体阳性NMOSD患者、18例复发缓解型MS患者和25名健康对照接受3T MRI,记录磁敏感加权成像上白质病灶内中央静脉(细低信号线或小点)的存在。
主要发现
- MS病灶中CVS比例高于NMOSD(80% vs 32%,p < 0.001)。
- CVS病灶比例较高预测MS而非NMOSD诊断(OR 1.10,95%CI 1.04–1.16,p = 0.001),即个体患者CVS病灶比例每增加1个百分点,该患者患MS的风险增加10%。
- 若任一次扫描中超过54%的病灶显示CVS,则诊断MS的准确率为94%(95%CI 81.34–99.32,p < 0.001),敏感度/特异度90%/100%。
关键数值与推荐
- CVS定义为磁敏感加权成像上白质病灶内的细低信号线或小点。
- MS病灶CVS比例80% vs NMOSD 32%(p < 0.001)。
- CVS病灶比例预测MS的OR 1.10(95%CI 1.04–1.16,p = 0.001)。
- 超过54%病灶显示CVS诊断MS的准确率94%(95%CI 81.34–99.32,p < 0.001),敏感度90%、特异度100%。
临床怎么用
- 本研究提供III级证据表明3T MRI上的CVS可准确区分MS与血清阳性NMOSD患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). METHODS: Eighteen aquaporin-4-antibody-positive patients with NMOSD, 18 patients with relapsing-remitting MS, and 25 healthy controls underwent 3T MRI. The presence of a central vein in white matter lesions on susceptibility-weighted imaging, defined as a thin hypointense line or a small dot, was recorded. RESULTS: The proportion of lesions with the CVS was higher in MS than NMOSD (80% vs 32%, p < 0.001). A greater proportion of lesions with the CVS predicted the diagnosis of MS, rather than NMOSD (odds ratio 1.10, 95% confidence interval [CI] 1.04 to 1.16, p = 0.001), suggesting that each percent unit increase in the proportion of lesions with the CVS in an individual patient was associated with a 10% increase in the risk of the same patient having MS. If more than 54% of the lesions on any given scan show the CVS, then the patient can be given a diagnosis of MS with an accuracy of 94% (95% CIs 81.34, 99.32, p < 0.001, sensitivity/specificity 90%/100%). CONCLUSION: The clinical value of the CVS in the context of the differential diagnosis between MS and NMOSD, previously suggested using 7T scanners, is now extended to clinical 3T scanners, thereby making a step towards the use of CVS in clinical practice. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that the CVS on 3T MRI accurately distinguishes patients with MS from those with seropositive NMOSD.
引用
- Cortese R, Magnollay L, Tur C, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018. PMID: 29514948. doi:10.1212/WNL.0000000000005256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。